Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VHL | P40337 | 1/20 | 0.46 |
| ▸ | ELOC | Q15369 | 1/20 | 0.46 |
| ▸ | ELOB | Q15370 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | AR | P10275 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | OGT | O15294 | 1/20 | 0.34 |
| ▸ | S100A4 | P26447 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18144907 | 0.82 | EDNRB (0.44) | HPGDKDM4ENPC1MAPTPKM | |
| SCHEMBL86878 | 0.80 | VHL (0.40) | VHLELOCELOBHPGDL3MBTL1 | |
| SCHEMBL85777 | 0.80 | KMT2A (0.40) | VHLELOCELOBHPGDGAA | |
| SCHEMBL68882 | 0.78 | VHL (0.43) | VHLELOCELOBHPGDL3MBTL1 | |
| SCHEMBL87186 | 0.78 | VHL (0.38) | VHLELOCELOBHPGDL3MBTL1 | |
| SCHEMBL2171598 | 0.78 | MAPT (0.50) | HPGDKDM4ENPC1MAPTPKM | |
| SCHEMBL86831 | 0.77 | MEN1 (0.41) | VHLELOCELOBHPGDL3MBTL1 | |
| SCHEMBL10534782 | 0.77 | HPGD (0.49) | VHLELOCELOBHPGDL3MBTL1 | |
| SCHEMBL67751 | 0.76 | KDM4E (0.54) | VHLELOCELOBHPGDL3MBTL1 | |
| SCHEMBL31355203 | 0.76 | KDM4E (0.54) | VHLELOCELOBHPGDL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113582970-B | Preparation method and application of thiochroman-4-one derivative containing amide and oxime or oxime ether structure | 凯里学院 | 2023-07-14 | — | — | CN | disclosed |
| CN-113956247-B | Preparation method and application of thiochroman-4-one derivative containing 1,3, 4-oxadiazole thioether and oxime ether structure | 凯里学院 | 2023-07-11 | — | — | CN | disclosed |
| CN-113956247-A | Preparation method and application of thiochroman-4-one derivative containing 1,3, 4-oxadiazole thioether and oxime ether structures | 凯里学院 | 2022-01-21 | — | — | CN | disclosed |
| CN-113582970-A | Preparation method and application of thiochroman-4-ketone derivative containing amide and oxime or oxime ether structures | 凯里学院 | 2021-11-02 | — | — | CN | disclosed |
| EP-2053095-B2 | Ink composition and inkjet recording method using the same | FUJIFILM CORP (JP) | 2017-02-22 | — | — | EP | disclosed |
| EP-2053095-B1 | Ink composition and inkjet recording method using the same | FUJIFILM CORP (JP) | 2014-03-26 | — | — | EP | disclosed |
| US-8129447-B2 | Ink composition and inkjet recording method using the same | FUJIFILM CORPORATION (JP) | 2012-03-06 | — | — | US | disclosed |
| US-8129447-B2 | Ink composition and inkjet recording method using the same | FUJIFILM CORPORATION (JP) | 2012-03-06 | — | — | US | disclosed |
| US-8097688-B2 | Ink composition and inkjet recording method | FUJIFILM CORPORATION (JP) | 2012-01-17 | — | — | US | disclosed |
| US-8097688-B2 | Ink composition and inkjet recording method | FUJIFILM CORPORATION (JP) | 2012-01-17 | — | — | US | disclosed |
| US-20100227076-A1 | INK COMPOSITION AND INKJET RECORDING METHOD | FUJIFILM CORPORATION (JP) | 2010-09-09 | — | — | US | disclosed |
| US-20100227076-A1 | INK COMPOSITION AND INKJET RECORDING METHOD | FUJIFILM CORPORATION (JP) | 2010-09-09 | — | — | US | disclosed |
| EP-2053095-A2 | Ink composition and inkjet recording method using the same | Fujifilm Corporation (JP) | 2009-04-29 | — | — | EP | disclosed |
| US-20090087575-A1 | INK COMPOSITION AND INKJET RECORDING METHOD USING THE SAME | FUJIFILM CORPORATION (JP) | 2009-04-02 | — | — | US | disclosed |
| US-20090087575-A1 | INK COMPOSITION AND INKJET RECORDING METHOD USING THE SAME | FUJIFILM CORPORATION (JP) | 2009-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090087575-A1 | INK COMPOSITION AND INKJET RECORDING METHOD USING THE SAME | RB1, IK, NOX1 | VHL 3930/4885ELOC 3228/4885ELOB 895/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.